Transplante autólogo de celulas tronco hematopoiéticas nos pacientes com linfoma de Hodgkin: análise de 106 pacientes

Cortez, Afonso José Pereira.
São Paulo; s.n; 2010. [107] p. tab, graf.
Tese em Português | LILACS | ID: lil-579244

Documentos relacionados

  1. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
  2. Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
  3. Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution.
  4. Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow-up of the multicenter, single-arm, Phase 2 study.
  5. Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma.
  6. Nodular lymphocyte predominant Hodgkin lymphoma: Experience of Polish Pediatric Leukemia/Lymphoma Study Group.
  7. Hodgkin lymphoma: A review and update on recent progress.
  8. How I treat nodular lymphocyte-predominant Hodgkin lymphoma.
  9. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor.
  10. Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach.